Inspired by our purpose to revolutionise care for people and planet, our sustainability roadmap 2030, WeCare, guides us and lends structure to our sustainability efforts. It is a driver for growth, innovation and productivity and an essential part of our employee value proposition.
Following a materiality analysis in 2021, we launched WeCare, an ambitious 2030 sustainability roadmap. Based on the Paris Agreement, and the UN Sustainable Development Goals, WeCare embeds social, environmental, and economic value for patients and healthcare providers across our product and service offering. It also directs how we conduct our business in the short- mid- and long-term to create a sustainable, equitable and inclusive future.
Mölnlycke performs a materiality analysis every second year to identify which issues to prioritise, manage and monitor to create shared value for society, the environment and the economy, as well as identify future challenges and opportunities for the company. In the latest materiality analysis carried out in 2022 various stakeholders, including Mölnlycke’s employees, customers, distributors, suppliers, national sector organisations and students helped to identify 20 material aspects that were of primary importance, and prepared the ground for the company’s WeCare roadmap.
The results showed that topics such as decent safe employment, diversity equity and inclusion, waste and circularity, sustainable innovation and development, and community support gained importance compared to the last materiality analysis in 2020. Other material aspects, such as biodiversity and responsible taxation approach, were found to have a lower significance (see the materiality matrix for details).
In 2023 Mölnlycke started to prepare for the Corporate Sustainability Reporting Directive (CSRD) and Corporate Sustainability Due Diligence Directive (CS3D) implementation by performing a Double Materiality assessment and consequent gap analysis
evaluation.
"Recognising the profound and ongoing pressure on environment, society and global healthcare systems in particular, Mölnlycke are accelerating our transformation to deliver sustainable healthcare solutions. We are uniquely positioned to improve patient lives while reducing the environmental impact of healthcare."
Zlatko Rihter Chief Executive Officer
We set high standards of ethics and responsibility in our business and act with integrity and care for human rights throughout our value chain.
We’ve formalised our climate change mitigation efforts with Science Based Targets initiative (SBTi) and our near-term greenhouse gas emission reduction targets were validated by SBTi. Find out what we've committed to.
Reducing absolute scope 1 and 2 GHG emissions by 50% by 2030 from a 2021 base year.
Increasing active annual sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024 and continuing active annual sourcing of 100% of renewable electricity through 2030.
Reducing absolute scope 3 GHG emissions from purchased goods and services (cat. 1), fuel and energy related activity (cat. 3), upstream transportation and distribution (cat. 4) and waste generated in operations (cat. 5) by 20% by 2028 from a 2021 base year.
Having 63% of our suppliers by emissions covering purchased goods and services (cat. 1) capital goods (cat. 2), and upstream transportation and distribution (cat. 4) committed to the Science Based Targets Initiative by 2028.
2016: Scope 1 and 2 GHG emissions measured and baseline established
2021: Materiality analysis and development of WeCare (2030 sustainability roadmap)
2021: Upstream and downstream scope 3 GHG emissions measured and baseline established
2021: First range of BARRIER® surgical drapes launched with ISCC-certified material
2022: Nine manufacturing sites operating on 100% fossil-free electricity
2023: Validation of near-term GHG emission reduction targets by SBTi
2023: Sustainable Product Portfolio Assessment conduced for two Business Areas
Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and planet contributed to a very successful year with record high annual net sales of EUR 1,924 million and substantial improvements in profitability. We continue to report our sustainability achievements in accordance with the Global Reporting Initiative (GRI) standards.
The benchmarking procedure Mölnlycke are in the second year of working with EcoVadis as an independent and credible organisation to benchmark strengths and improvement opportunities. The rating process required extensive amounts of data and documentation, and therefore teamwork between global sustainability, legal and compliance, information technology, procurement excellence, and people experience teams. Our submission was assessed over a four week period. As a continuation from the previous assessment, results and feedback will be used to prioritise improvement plans. The result A gold medal is awarded to the all top 5%, and our score puts us into the top 3% of all organisations from all industries worldwide. Particularly recognized during the submission were Mölnlycke's commitment to Science Based Targets and measurable improvements in emissions, the strength of Mölnlycke procedures relating to human rights, demonstrable progress in gender equality, and the availability of the Ethics Hotline to all Mölnlycke's stakeholders The results certificate is available to download for verification below, EcoVadis will also provide a detailed validated scorecard to users of their platform.